1.00
price down icon3.85%   -0.04
 
loading

Finanzdaten der Immunic Inc-Aktie (IMUX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.14%
23.88
23.38 23.57 25.02 27.25
Operating Income/Loss
2.14%
-23.88
-23.38 -23.57 -25.02 -27.25
Nonoperating Income/Loss
415.26%
-5.703
1.809 0.801 1.022 1.979
Income/Loss From Continuing Operations Before Tax
37.14%
-29.58
-21.57 -22.77 -24.00 -25.27
Income/Loss From Continuing Operations After Tax
37.14%
-29.58
-21.57 -22.77 -24.00 -25.27
Net Income/Loss
37.14%
-29.58
-21.57 -22.77 -24.00 -25.27
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
104.76K%
97.30
0.0928 44.57 44.43 43.66
Diluted Average Shares
104.76K%
97.30
0.0928 44.57 44.43 43.66
Basic Earnings Per Share
37.50%
-0.30
-0.48 -0.51 -0.54 -0.58
Diluted Earnings Per Share
37.50%
-0.30
-0.48 -0.51 -0.54 -0.58
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):